title: Hyperglycosylation prolongs the circulation of coagulation factor IX.
authors.affiliation: Mammalian Cell Technology Protein Purification Exploratory ADME Biopharmaceuticals, Novo Nordisk A/S, Måløv, Denmark.
authors.forename: G
authors.initials: G
authors.lastname: Bolt
authors.forename: J R
authors.initials: JR
authors.lastname: Bjelke
authors.forename: M B
authors.initials: MB
authors.lastname: Hermit
authors.forename: L
authors.initials: L
authors.lastname: Hansen
authors.forename: D M
authors.initials: DM
authors.lastname: Karpf
authors.forename: C
authors.initials: C
authors.lastname: Kristensen
mesh_terms: D000818:Animals; D018076:DNA, Complementary / Q000378:metabolism; D015195:Drug Design; D005164:Factor IX / Q000737:chemistry*; D006031:Glycosylation; D006467:Hemophilia A / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D051379:Mice; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011134:Polysaccharides / Q000737:chemistry; D011994:Recombinant Proteins / Q000737:chemistry; D013997:Time Factors
chemical_list: D018076:DNA, Complementary; D011134:Polysaccharides; D011994:Recombinant Proteins; D005164:Factor IX